ARTICLE | Company News
Endovasc, MIV Therapeutics deal
May 26, 2003 7:00 AM UTC
MITV said it will not extend a 2002 license agreement with ENDV to develop ENDV's PROstent Prostaglandin E-1 coating for use with MIVT's laser cut coronary stent delivery system to treat restenosis (s...